{
    "organizations": [],
    "uuid": "1fc349a7ab44bfc0f5e40f7faf358d415bd8898f",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-epigenomics-blood-test-shows-promi/brief-epigenomics-blood-test-shows-promise-in-the-detection-of-liver-cancer-idUSFWN1RV11J",
    "ord_in_thread": 0,
    "title": "BRIEF-Epigenomics: Blood Test Shows Promise In The Detection Of Liver Cancer",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 19 (Reuters) - Epigenomics AG:\n* DGAP-NEWS: EPIGENOMICS AG: BLOOD TEST SHOWS PROMISE IN THE DETECTION OF LIVER CANCER\n* RESULTS FROM TWO CLINICAL STUDIES DEMONSTRATE HIGH SENSITIVITY AND SPECIFICITY OF MSEPT9 BLOOD TEST Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-04-19T12:41:00.000+03:00",
    "crawled": "2018-04-20T11:50:44.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "epigenomics",
        "ag",
        "epigenomics",
        "ag",
        "blood",
        "test",
        "show",
        "promise",
        "detection",
        "liver",
        "cancer",
        "result",
        "two",
        "clinical",
        "study",
        "demonstrate",
        "high",
        "sensitivity",
        "specificity",
        "msept9",
        "blood",
        "test",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}